Studies of Avian Influenza Transmission to Humans in Egypt

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT01150552
First received: June 22, 2010
Last updated: July 9, 2012
Last verified: July 2012

June 22, 2010
July 9, 2012
June 2010
April 2014   (final data collection date for primary outcome measure)
  • Measure antibodies in sera collected from poultry-exposed and non-exposed individuals [ Time Frame: 4 years ] [ Designated as safety issue: No ]
    Prevalence rates will be measured by the presence of antibodies against AI viruses of types H4-H12 using a microneutralization assay.
  • Draw 3 annual serum samples from each individual and record any increase in the antibody titers against AI viruses. [ Time Frame: 4 years ] [ Designated as safety issue: No ]
    Incidence rates will be assessed based on a 2-fold increase of antibody titers between baseline and follow-up and between follow-up and the final visit.
  • Risk or protective factors correlated with infection will be measured using the enrollment questionnaire. [ Time Frame: 4 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01150552 on ClinicalTrials.gov Archive Site
  • Obtain nasal and naso-pharyngeal swabs from subjects reporting ILI symptoms and confirm the presence of influenza by a rapid test. [ Time Frame: 4 years ] [ Designated as safety issue: No ]
    Obtain swabs from the household contacts of individuals with a confirmed influenza A infection and test them for the presence of influenza A viruses
  • To send RT-PCR positive specimens collected from subjects reporting ILI symptoms to the hospital in order to isolate and characterize the virus. [ Time Frame: 4 years ] [ Designated as safety issue: No ]
  • Collect data on disease pathogenicity and severity of symptoms from subjects reporting ILI and obtain a blood sample to isolate and study peripheral blood mononuclear cells. [ Time Frame: 4 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Studies of Avian Influenza Transmission to Humans in Egypt
Prospective Studies of Avian Influenza Transmission to Humans in Egypt

The main focus of the study is:

  • To estimate seroprevalence of AI in poultry-exposed and non-exposed human populations.
  • To estimate the incidence of AI in poultry-exposed and non-exposed human populations.
  • To investigate risk factors associated with AI infections in occupationally-exposed poultry workers.

The secondary objectives of the study:

  • To investigate patterns in transmission of AI to household contacts of AI clinical cases
  • To isolate AI viruses from acute cases
  • To monitor the pathogenicity and disease severity of AI viruses causing human infections

This 4-year prospective cohort study to compare individuals with occupational exposure to poultry with non-poultry exposed adult controls for evidence of incident and previous infections with AI viruses. At the start of this study, study staff will obtain informed consent, and a blood sample will be obtained from study volunteers to establish baseline levels of antibodies against avian influenza types H4-H12. Subjects will be interviewed regarding their exposures, medical history, and behaviors using a close-ended questionnaire specifically tailored for this study. After one year, study subjects will be interviewed again to note any changes in exposure variables. At this time, another blood sample will be obtained and tested for any changes in antibodies' levels. The same procedures will be repeated at the final visit after another year. Exposed individuals will be selected from rural areas where poultry is commonly raised. Non-exposed controls will be selected from urban neighborhoods in Cairo.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Sera will be tested for human antibodies against AI viruses (types H4-H12) using a microneutralization assay. Study sera will be examined for antibodies against human influenza types H1 and H3 using a hemagglutination inhibition procedure.

Probability Sample

Exposed subjects will be enrolled at the rural areas of Egypt where poultry production is located. Controls will be enrolled in urban Cairo. Households will be selected from neighborhoods without live bird markets close to the location of the NRC. All members of a household will be enrolled. Cohort of exposed subjects will be assembled from villages from 3 governorates in this area as well as 2 governorates south of Cairo where human cases of AI were reported. Hence, 5 villages will make up 5 field sites. From each village, the team will enroll 150 individuals with exposure to poultry. The control group, i.e., individuals not occupationally exposed to poultry, will be enrolled from urban Cairo, the capital of Egypt.

Avian Influenza
Not Provided
  • Poultry exposed individuals
    Any individual who had an occupational contact with poultry in the previous five years will be considered exposed. Individuals working on poultry farms, poultry wet markets, or keeping limited numbers of poultry in their backyard, are considered exposed.
  • Non-poultry exposed adult controls
    Unexposed individuals must have no occupational exposure to poultry in their lifetime and must also not be exposed to poultry purchased from live bird markets.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1000
April 2014
April 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Be willing to participate by signing a consent/assent form, completing the study questionnaire, and permitting the withdrawal of blood.
  • Does not buy poultry from live bird markets (for controls only).

Exclusion Criteria:

  • Any known immunosuppressive condition or immune deficiency disease (including HIV infection), or ongoing receipt of any immunosuppressive therapy.
  • Any individual with unknown poultry exposure status, or who was exposed to poultry more than 5 years ago.
  • Children who are less than 2 years old when baseline enrollment is performed.
Both
2 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Egypt
 
NCT01150552
EGYFLU XPD09-211, HHSN266200700005C
No
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Institutes of Health (NIH)
Principal Investigator: Ghazi Kayali, Ph.D St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP